Self-Monitoring of Blood Glucose Market Share, Demand & Growth by 2034

Coverage: By Product Type (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets. On the basis of application, the market is categorized as Hospitals, Home Settings, Diagnostic Centers), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00015252
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Self-Monitoring of Blood Glucose Market Share, Demand & Growth by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00015252 Email: sales@theinsightpartners.com

2025 Market Size

US$ 22.4 Bn

Base year value

2034 Forecast

US$ 60.58 Bn

Projected by 2034

CAGR 2026-2034

11.69 %

Growth rate

Addressable Market

US$ 364.85 Bn

(2026-2034)

The Self-Monitoring of Blood Glucose Market size is expected to reach US$ 60.58 Billion by 2034 from US$ 22.4 Billion in 2025. The market is estimated to record a CAGR of 11.69% from 2026 to 2034.

MARKET INTRODUCTION

Monitoring blood glucose is an important diabetes management step. Blood glucose tracking systems are primarily used to monitor a patient's blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and allow users to monitor their blood glucose level regardless of location. Includes test sticks, lancets and blood glucose metres to track blood glucose levels.

MARKET DYNAMICS

The incidences of diabetes among ageing population globally, growing demand for glycemic regulation and raising need to avoid hypoglycemia are pushing demand on the global SMBG market. Self-monitoring blood glucose procedure helps enhance hypoglycemia identification and encourages patients to permit adverse effects of pharmaceutical action. Rising demand for constant blood sugar regulation, and rising need to regulate blood glucose levels to remain stable and fit, also fuel the global SMBG industry.

Market Research Highlights

  • Global market for Self-Monitoring of Blood Glucose was valued at US$ 22.40 Billion in 2025
  • Annual market size is expected to reach US$ 60.58 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 364.85 Billion
  • Market is anticipated to register a CAGR of 11.69% during the forecast period
  • The United States represents a key market, supported by Empowering Patients: The Rise of Self-Monitoring Tech, Revolutionizing Diabetes Care with Smart Devices, Personalized Health Insights: The Future of Blood Glucose Management, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Revolutionizing Diabetes Care: Smart Glucose Monitoring Devices, Personalized Health: The Rise of Continuous Glucose Monitoring, Empowering Patients: The Future of Self-Monitoring Technologies are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Lifescan, Ascensia, Arkray, Abbott, F. Hoffmann-La Roche AG, Dexcom, Johnson and Johnson, Medtronic, Ascensia Diabetes Care Holdings AG, B. Barun Melsungen AG, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Self-Monitoring of Blood Glucose Market: Strategic Insights

self-monitoring-of-blood-glucose-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

The "Self-Monitoring of Blood Glucose Market Analysis to 2034" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Self-Monitoring of Blood Glucose market with detailed market segmentation by product type, and application. The Self-Monitoring of Blood Glucose market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Self-Monitoring of Blood Glucose market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Self-Monitoring of Blood Glucose market is segmented on the basis of product type, and end use. Based on type, the market is segmented as Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets. On the basis of application, the market is categorized as Hospitals, Home Settings, Diagnostic Centers.

Self-Monitoring of Blood Glucose Market Report Scope

Report Attribute Details
Market size in 2025 US$ 22.4 Billion
Market Size by 2034 US$ 60.58 Billion
Global CAGR (2026 - 2034) 11.69%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product Type
  • Self-monitoring Blood Glucose Meters
  • Continuous Glucose Monitors
  • Testing Strips
  • Lancets. On the basis of application
  • the market is categorized as Hospitals
  • Home Settings
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Lifescan
  • Ascensia
  • Arkray
  • Abbott
  • F. Hoffmann-La Roche AG
  • Dexcom
  • Johnson and Johnson
  • Medtronic
  • Ascensia Diabetes Care Holdings AG
  • B. Barun Melsungen AG

Self-Monitoring of Blood Glucose Market Players Density: Understanding Its Impact on Business Dynamics

The Self-Monitoring of Blood Glucose Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

self-monitoring-of-blood-glucose-market-cagr

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Self-Monitoring of Blood Glucose market based on various segments. It also provides market size and forecast estimates from year 2021 to 2034 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Self-Monitoring of Blood Glucose market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.The report analyzes factors affecting Self-Monitoring of Blood Glucose market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Self-Monitoring of Blood Glucose market in these regions.

MARKET PLAYERS

The report covers key developments in the Self-Monitoring of Blood Glucose market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Self-Monitoring of Blood Glucose market are anticipated to have lucrative growth opportunities in the future with the rising demand for Self-Monitoring of Blood Glucose in the global market. Below mentioned is the list of few companies engaged in the Self-Monitoring of Blood Glucose market.The report also includes the profiles of key players in Self-Monitoring of Blood Glucose market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  1. Lifescan
  2. Ascensia
  3. Arkray
  4. Abbott
  5. F. Hoffmann-La Roche AG
  6. Dexcom
  7. Johnson and Johnson
  8. Medtronic
  9. Ascensia Diabetes Care Holdings AG
  10. B. Barun Melsungen AG
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA